Dxcover is a clinical stage liquid biopsy company that focuses on the early detection of multiple cancers for more effective treatment outcomes. Using infrared spectroscopy of circulating pan-omic biomarkers, the company has pioneered the early detection and identification of cancer, with compelling clinical data showcasing high accuracy detection of Stage I and Stage II cancers. Founded in 2016 and based in Scotland, United Kingdom, Dxcover is expanding its operations to the USA. The company secured a significant £7.50M Series A investment on 01 February 2023, with backing from notable investors including SIS Ventures, Scottish Enterprise, Eos, Mercia Fund Managers, Mark Bamforth, Norcliffe Capital, and University of Strathclyde.
General Information
BounceWatch is an independent company data service, not affiliated with Dxcover. To contact Dxcover, visit dxcover.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Dxcover compare?
A PDF of Dxcover and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Dxcover soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Dxcover on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Dxcover
Business keywords: Liquid biopsy, Cancer diagnostics, Early detection, Infrared spectroscopy, Clinical stage, Biomarkers, Scotland, USA, Biotech, Oncology, Medical technology
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | £7.50M | 7 | 01 Feb 2023 | |
| Grant | £2.20M | 1 | 21 Dec 2022 | |
| Seed Round | £1.10M | 3 | 04 Mar 2021 | |
| Seed Round | £2.40M | 5 | 07 Sep 2020 | |
| Seed Round | £1.20M | 2 |
Scottish Investment Bank, Mercia Fund Managers
|
02 May 2019 |
| Grant | Undisclosed | 2 | 11 Feb 2019 |
Dxcover Alternatives & Competitors
View All AlternativesPioneering Life-Saving Cancer Detection with Advanced Liquid Biopsy Solutions
THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™
FAQ About Dxcover
Source: BounceWatch company record for Dxcover, https://bouncewatch.com/company/dxcover, updated 10 October 2024. When citing, please name BounceWatch and link this page.